Abstract:Surgical bypass has traditionally been the gold standard for treating critical limb ischemia caused by isolated infrapopliteal arterial disease (IP CLI). However, as endovascular techniques continue to progress, they are increasingly applied to this patient population, especially to the high-risk surgical cohort or patients with limited surgical options. This enthusiasm to employ endovascular interventions in IP CLI is accompanied by persistent controversies, as demonstrated in the recent literature. Percutaneous transluminal balloon angioplasty has been the predominant endovascular intervention applied to treat IP CLI and recent literature supports its role. The durability of percutaneous transluminal balloon angioplasty is limited, and thus this intervention is recommended for high-risk patients with limited life expectancy. Bare-metal stents for IP CLI currently do not have supportive data to warrant their use as a primary treatment. Newer drug-eluting stents improve patency and prevent restenosis, but they do not significantly improve patient clinical status compared with bare-metal stents alone. Drug-coated balloons are still relatively new tools in this arena and evidence of their safety and clear efficacy are still lacking. The data on atherectomy, in all of its forms, for IP CLI are overall variable, without any clear benefit to justify its increased complication risks and costs over other modalities. Use of retrograde tibial/pedal access for treating IP CLI as a viable alternative to antegrade access and treatment from a totally retrograde approach has recently been described. Level I evidence to aid in clarifying the true efficacy for each of these endovascular modalities is greatly needed. As we await these data, we must remember that, as with any arterial intervention, proper patient selection is extremely important and the intervention, whether endovascular or open surgical repair, should be tailored to the individual patient's anatomy and disease characteristics.

[Progress and prospect of the treatment of lower extremity arteriosclerosis obliterans].

Endovascular treatment of lower extremity arteriosclerosis obliterans of TASC-D type：its current clinical situation

Endovascular intervention for tibial artery occlusive disease in patients with critical limb ischemia

[Progress and prospect of excimer laser ablation in the treatment of therosclerotic obliterans].

Endovascular therapy for critical limb ischemia

Diagnosis and Treatment of Lower Extremity Vascular Injury

Current status and challenges over interventional treatment of lower limb arterial diseases

Endovascular treatment of femoropopliteal atherosclerotic occlusive disease

Arteriosclerosis Obliterans in the Lower Extremities in Forty-eight Cases

[Analysis of Cause and Treatment of Acute Limb Ischemia Complicated in Peripheral Endovascular Interventions].

Advances for the treatment of lower extremity arterial disease associated with diabetes mellitus

[Endovascular Revascularization for Lower Extremity Atherosclerosis Obliterans in Elderly Patients:A Report of 86 Cases].

The Double Burden: Deciphering Chronic Limb-Threatening Ischemia in End-Stage Renal Disease

Analysis of results of the below-the-knee endovascular therapy for critical limb ischemia

Surgery for lower-extremity arteriosclerotic occlusive disease

The Contemporary Role of Stents and Angioplasty for the Treatment of Infrapopliteal Disease in Critical Limb Ischemia

Endovascular techniques in limb salvage: infrapopliteal angioplasty

Lower extremity critical limb ischemia: A review of clinical features and management

Below-the-Knee Endovascular Revascularization

Intravascular interventional therapy combined with convention surgery for treatment of lower extremity multilevel atherosclerotic occlusive disease

Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations.